Clinical Trials Browser

Skin Neoplasms × Standard of Care × 90 days × Clear all

NCT06585410 2026-04-22

Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

Phase 3 Recruiting

Skin Neoplasms